Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

8-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in children in Nepal (TyVOID): a prospective cohort follow-up study of the TyVAC Nepal randomised controlled trial.

Pant D. et al, (2027), Lancet Glob Health

Severe anaemia and invasive bacterial infections in Kenyan children: a 26-year hospital surveillance observational study.

Abuga KM. et al, (2027), Lancet Glob Health

Developing a global framework to assess a country's readiness and resilience to introduce a new vaccine or improve uptake of an underutilized vaccine.

Monk V. et al, (2026), Expert Rev Vaccines, 25

The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19.

Kazungu Y. et al, (2026), Virulence, 17

Parental motivations, facilitators, and barriers to participating in a pediatric vaccine trial in Kathmandu, Nepal: A qualitative study.

Firth C. et al, (2026), Hum Vaccin Immunother, 22

What is unhealthy about public health? Vaccination, evidence and the politics of uncertainty

Mezza M. and Vanderslott S., (2026), Humanities and Social Sciences Communications, 13

Cellular immunity to Streptococcus pneumoniae: implications for vaccine-mediated prevention

VanSeggelen H. et al, (2026), Expert Review of Vaccines, 25

Timing matters: Exon skipping therapy is most effective when initiated early in a mouse model of Duchenne muscular dystrophy.

Stenler S. et al, (2026), Mol Ther Nucleic Acids, 37

Accurately modeling RNase H-mediated antisense oligonucleotide efficacy.

Hill B. et al, (2026), Mol Ther Nucleic Acids, 37

TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMT.

Prunotto G. et al, (2026), J Hum Immun, 2

Seroefficacy of a 10-valent pneumococcal conjugate vaccine (Pneumosil®) compared with other pneumococcal conjugate vaccines in children.

Akeju O. et al, (2026), Vaccine, 90

Muscle MRI as an Imaging Biomarker of Muscle Damage in Patients With Spinal and Bulbar Muscular Atrophy.

Grunseich C. et al, (2026), Neurology, 107

Neutralising autoantibodies against IL-10 and HLA-DRB1*01:03 in paediatric patients with inflammatory bowel disease.

Gharahdaghi N. et al, (2026), Gut

Kinetic profile and mucosal capsular polysaccharide IgG responses to serotype 3 pneumococcus in the adult oropharynx following an experimental human challenge

Robinson RE. et al, (2026), Frontiers in Microbiology, 17

Ly6d expression delineates two putative postnatal thymus epithelial progenitor cells that are differentially affected by aging.

Calvo-Asensio I. et al, (2026), Sci Adv, 12

Load More

1
2
3
4
5
6
7
...
»